Laboratorios Farmaceuticos Rovi, S.A. Stock
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
BME
11:35:28 2026-09-01 am EDT
|
5-day change | 1st Jan Change | ||
| 60.00 EUR | -0.99% |
|
+0.25% | -5.51% |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.07B 3.56B 2.89B 2.63B 4.94B 338B 4.98B 34.19B 13.29B 172B 13.35B 13.06B 570B | P/E 2026 * |
21.5x | P/E 2027 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.05B 3.54B 2.87B 2.62B 4.92B 336B 4.95B 34.01B 13.22B 171B 13.28B 12.99B 567B | EV / Sales 2026 * |
3.96x | EV / Sales 2027 * | 3.35x |
| Free-Float |
31.63% | Yield 2026 * |
1.61% | Yield 2027 * | 1.95% |
Last Transcript : Laboratorios Farmaceuticos Rovi, S.A.
| Jul. 23 | Spanish stocks - Factors to watch on July 23 | RE |
| Feb. 25 | Spanish stocks - Factors to watch on Feb 25 | RE |
| Nov. 06 | Spanish stocks - Factors to watch on Nov 6 | RE |
| 25-03-05 | Spanish stocks - Factors to watch on March 5 | RE |
| 1 day | -0.99% | ||
| 1 week | +0.25% | ||
| Current month | -0.99% | ||
| 1 month | +2.48% | ||
| 3 months | +1.18% | ||
| 6 months | -29.20% | ||
| Current year | -5.51% |
| 1 week | 59.8 |  | 62.2 |
| 1 month | 57.3 | | 62.2 |
| Current year | 53.1 | | 86.7 |
| 1 year | 53.1 | | 86.7 |
| 3 years | 45.52 | | 94.8 |
| 5 years | 35.2 | | 94.8 |
| 10 years | 10.8 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2007-07-26 | |
| Director of Finance/CFO | - | 2000-12-31 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2021-07-16 | |
| Director/Board Member | - | 2007-07-26 | |
| Director/Board Member | - | 2007-07-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/23/23 | Buy | Director | 1,000 | 0.0019% | ||
| 4/13/22 | Norbel Inversiones SL
| Sell | Company | 560,690 | 1.0000% | |
| 3/15/22 | Norbel Inversiones SL
| Sell | Company | 2,803,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.99% | +0.25% | +3.45% | +14.29% | 3.6B | |
| +0.28% | -6.97% | +58.34% | +109.31% | 1,031B | |
| +2.01% | -0.68% | +53.07% | +67.73% | 641B | |
| +1.39% | -1.71% | +23.57% | +76.91% | 453B | |
| -1.50% | -6.18% | +33.50% | +33.50% | 349B | |
| +6.25% | +3.31% | +29.46% | +46.64% | 290B | |
| -0.07% | -1.22% | +1.46% | +12.19% | 252B | |
| +1.92% | -1.29% | +52.28% | +70.91% | 232B | |
| +0.51% | -1.79% | -18.09% | -53.86% | 201B | |
| +2.45% | +2.17% | +32.71% | +96.03% | 181B | |
| Average | +0.93% | -2.56% | +26.97% | +47.36% | 363.34B | |
| Weighted average by Cap. | +1.23% | -3.97% | +38.50% | +66.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 772M 895M 726M 662M 1.24B 84.95B 1.25B 8.6B 3.34B 43.22B 3.36B 3.28B 143B | 891M 1.03B 838M 764M 1.44B 98.06B 1.45B 9.92B 3.86B 49.89B 3.88B 3.79B 165B |
| Net income | 129M 149M 121M 110M 207M 14.15B 209M 1.43B 557M 7.2B 559M 547M 23.87B | 174M 202M 164M 149M 280M 19.14B 282M 1.94B 753M 9.74B 757M 740M 32.29B |
| Net Debt | -16.21M -18.8M -15.26M -13.91M -26.12M -1.78B -26.3M -181M -70.21M -908M -70.56M -69.02M -3.01B | -81.51M -94.51M -76.69M -69.91M -131M -8.97B -132M -908M -353M -4.57B -355M -347M -15.14B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | €60.00 | -0.99% | 77,364 |
| 26-08-31 | €60.60 | -0.41% | 127,383 |
| 26-08-28 | €60.85 | -1.06% | 106,765 |
| 26-08-27 | €61.50 | +1.15% | 154,874 |
| 26-08-26 | €60.80 | +0.50% | 110,459 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
